Other
Neoplasm by Morphology
CI-CAN-00000002Explore in graph →
Non-malignant13,319 active trials222 approved drugs2,774 evidence items
- NCIt
- C4741
Loading cancer entity…
Other
CI-CAN-00000002Explore in graph →
Clinical trials
52,657 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00154986 | IGFBP-3 in Ovarian Cancer Invasion | unknown | N/A | 30 | National Taiwan University HospitalOTHER | 1 | Sep 12, 2005 | clinicaltrials |
| NCT00155181 | Molecular Mechanism of Nasopharyngeal Carcinoma | unknown | — | 25 | National Taiwan University HospitalOTHER | 1 | Sep 12, 2005 | clinicaltrials |
| Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma |
| unknown |
| Phase 1 / Phase 2 |
| 19 |
| National Taiwan University HospitalOTHER |
| 1 |
| Sep 12, 2005 |
| clinicaltrials |
| NCT00155844 | Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier" | unknown | — | 30 | National Taiwan University HospitalOTHER | 1 | Sep 12, 2005 | clinicaltrials |
| NCT00131313 | Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. | unknown | Phase 4 | 180 | East Valley Hematology and Oncology Medical GroupOTHER | 1 | Aug 18, 2005 | clinicaltrials |
| NCT00006200 | Thalidomide and Dacarbazine for Metastatic Melanoma | unknown | Phase 2 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00006431 | Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA | unknown | Phase 1 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00022880 | Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia | unknown | Phase 1 | 30 | Corixa CorporationINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00022893 | Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma | unknown | N/A | — | Corixa CorporationINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
| NCT00022906 | Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement | unknown | Phase 1 | 24 | Corixa CorporationINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00022932 | Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP | unknown | Phase 2 | — | Corixa CorporationINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00022958 | Expanded Access Study of Iodine-131 Anti-B1 Antibody | unknown | N/A | — | Corixa CorporationINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00036426 | Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma | unknown | Phase 2 | 22 | FavrilleINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00040560 | Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer | unknown | Phase 1 | — | CopharosINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00043433 | Study of T900607-Sodium in Chemotherapy Naive Patients With Hepatocellular Carcinoma. | unknown | Phase 2 | 35 | TularikINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
| NCT00052130 | Vaccine Therapy for Patients With Stage III Melanoma | unknown | Phase 3 | 1,118 | CancerVax CorporationINDUSTRY | 13 | Jun 24, 2005 | clinicaltrials |
| NCT00052156 | Vaccine Therapy for Patients With Stage IV Melanoma | unknown | Phase 3 | 670 | CancerVax CorporationINDUSTRY | 13 | Jun 24, 2005 | clinicaltrials |
| NCT00054951 | Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads | unknown | Phase 1 / Phase 2 | 30 | FeRxINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00057395 | A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 40 | Aronex PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00081783 | Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients | unknown | Phase 2 | 40 | Xcyte TherapiesINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Sep 12, 2005source: clinicaltrials